Viewing Study NCT04850950


Ignite Creation Date: 2025-12-24 @ 4:47 PM
Ignite Modification Date: 2025-12-27 @ 8:19 PM
Study NCT ID: NCT04850950
Status: UNKNOWN
Last Update Posted: 2021-04-23
First Post: 2021-04-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B
Sponsor: The First Affiliated Hospital of Zhengzhou University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2021-KY-0144-002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER_GOV View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER_GOV View
None OTHER View
None OTHER View
None UNKNOWN View
None UNKNOWN View
None OTHER View
None OTHER View
None OTHER View
None UNKNOWN View